Stroke in heart failure in sinus rhythm: The warfarin versus aspirin in reduced cardiac ejection fraction trial

Cerebrovascular Diseases

Volumn 36, Issue 1, 2013, Pages 74-78

  Pullicino, Patrick M ^a   Thompson, John L P ^b   Sacco, Ralph L ^d   Sanford, Alexandra R ^b   Qian, Min ^b   Teerlink, John R ^f   Haddad, Haissam ⁱ   Diek, Monika ^j   Freudenberger, Ronald S ^g   Labovitz, Arthur J ^e   Di Tullio, Marco R ^b   Lok, Dirk J ^k   Ponikowski, Piotr ^l   Anker, Stefan D ^j,m   Graham, Susan ^c   Mann, Douglas L ^h   Mohr, J P ^b   Homma, Shunichi ^b  

^a UNIVERSITY OF KENT   (United Kingdom)

^b Department of Medicine   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g LEHIGH VALLEY HOSPITAL   (United States)

^h WASHINGTON UNIVERSITY   (United States)

ⁱ UNIVERSITY OF OTTAWA   (Canada)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k Hospital Deventer   (Netherlands)

^l MILITARY HOSPITAL   (Poland)

^m IRCCS SAN RAFFAELE PISANA   (Italy)

more..

Author keywords

Aspirin; Cardiac embolism; Heart failure; Stroke prevention

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; ASPIRIN; BRAIN DAMAGE, CHRONIC; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; HEART FAILURE; HUMANS; INTRACRANIAL EMBOLISM; MULTICENTER STUDIES AS TOPIC; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; SEVERITY OF ILLNESS INDEX; STROKE; STROKE VOLUME; WARFARIN;

EID: 84881006186     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000352058     Document Type: Article

References (11)

1. Pullicino P, Homma S, Thompson JLP, Freudenberger RS, Sacco RL, Mohr JP. Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm. Cerebrovasc Dis 2008; 26: 322-327
2. Gibbs CR, Blann AD, Watson RD, Lip GY. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy. Circulation 2001; 103: 1746-1751
3. Gottdiener JS, Gay JA, Van Voorhees L, Di Bianco R, Fletcher RD. Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by 2-dimensional echocardiography. Am J Cardiol 1983; 52: 1281-1285
4. Pullicino P, Thompson JLP, Barton B, Levin B, Graham S, Freudenberger RS, WARCEF Investigators: Warfarin versus Aspirin in Patients with Reduced Cardiac Ejection Fraction (WARCEF): rationale, objectives and design. J Cardiac Fail 2006; 12: 39-46
5. Homma S, Thompson JLP, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 2012; 366: 1859-1869
6. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a metaanalysis. Ann Intern Med 1999; 131: 492-501
7. Miller VT, Pearce LA, Feinberg WM, Rothrock JF, Anderson DC, Hart RG, Stroke Prevention in Atrial Fibrillation Investigators: Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation. Neurology 1996; 46: 238-240
8. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III, TOAST Investigators: Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993; 24: 35-41
9. Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, Nasco E, SPAF Investigators: Cardioembolic vs noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic effect in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis 2000; 10: 39-43
10. Eikelboom JW, Connolly SJ. Warfarin in heart failure. N Engl J Med 2012; 366: 1936-1938
11. Marrone LCP, Marrone ACH. Acute ischemic stroke and new anticoagulants-how to act in the acute phase of stroke. Cerebrovasc Dis 2013; 35: 91